Your browser is no longer supported. Please, upgrade your browser.
Settings
IRTC iRhythm Technologies, Inc. daily Stock Chart
IRTC [NASD]
iRhythm Technologies, Inc.
Index- P/E- EPS (ttm)-2.13 Insider Own1.50% Shs Outstand26.84M Perf Week44.17%
Market Cap5.12B Forward P/E- EPS next Y-1.15 Insider Trans-41.36% Shs Float26.78M Perf Month60.51%
Income-55.40M PEG- EPS next Q-0.80 Inst Own- Short Float15.16% Perf Quarter54.11%
Sales229.80M P/S22.29 EPS this Y-2.40% Inst Trans0.34% Short Ratio9.87 Perf Half Y105.33%
Book/sh4.66 P/B39.57 EPS next Y45.50% ROA- Target Price130.20 Perf Year146.25%
Cash/sh4.38 P/C42.06 EPS next 5Y- ROE- 52W Range56.24 - 191.98 Perf YTD170.80%
Dividend- P/FCF- EPS past 5Y-22.40% ROI-32.20% 52W High-3.95% Beta1.40
Dividend %- Quick Ratio3.50 Sales past 5Y58.10% Gross Margin75.30% 52W Low227.86% ATR10.48
Employees997 Current Ratio3.60 Sales Q/Q31.50% Oper. Margin- RSI (14)79.31 Volatility12.44% 7.32%
OptionableYes Debt/Eq0.28 EPS Q/Q-0.20% Profit Margin- Rel Volume1.76 Prev Close190.09
ShortableYes LT Debt/Eq0.24 EarningsAug 06 AMC Payout- Avg Volume411.11K Price184.39
Recom1.80 SMA2046.08% SMA5051.42% SMA20098.57% Volume723,101 Change-3.00%
Aug-05-20Upgrade Oppenheimer Perform → Outperform $200
Mar-05-20Initiated Citigroup Buy $120
Feb-06-20Initiated BTIG Research Buy $90
Jan-10-20Initiated William Blair Outperform
Jan-08-20Initiated SunTrust Buy $102
Oct-22-19Initiated Oppenheimer Perform
Feb-20-19Downgrade Chardan Capital Markets Buy → Neutral $111 → $104
Sep-13-18Reiterated Canaccord Genuity Buy $93 → $100
Sep-06-18Initiated Chardan Capital Markets Buy $117
Aug-02-18Upgrade Dougherty & Company Sell → Neutral
Jul-16-18Downgrade Dougherty & Company Neutral → Sell
Dec-01-17Initiated Dougherty & Company Neutral
Aug-06-20 07:06PM  
04:05PM  
Aug-04-20 04:05PM  
02:01PM  
09:00AM  
07:13AM  
Jul-30-20 12:33PM  
Jul-29-20 04:05PM  
Jul-27-20 03:30PM  
Jul-21-20 04:05PM  
04:05PM  
Jun-30-20 11:59PM  
Jun-16-20 01:33PM  
Jun-04-20 04:15PM  
May-09-20 12:01AM  
May-07-20 08:50PM  
04:05PM  
May-04-20 07:14AM  
Apr-30-20 12:33PM  
Apr-29-20 04:05PM  
09:00AM  
Apr-28-20 12:33PM  
Apr-23-20 04:05PM  
Apr-18-20 10:17AM  
Apr-17-20 08:22PM  
Apr-09-20 04:03PM  
Mar-31-20 08:28AM  
Mar-01-20 08:34AM  
Feb-27-20 05:25PM  
04:05PM  
Feb-20-20 12:31PM  
Feb-11-20 02:35PM  
Feb-10-20 04:05PM  
Feb-04-20 12:30PM  
Feb-03-20 03:21PM  
Jan-27-20 03:00PM  
Jan-07-20 08:00AM  
Dec-30-19 04:05PM  
Dec-23-19 07:00AM  
Dec-22-19 05:05AM  
Dec-16-19 04:05PM  
Dec-10-19 07:47PM  
Nov-25-19 08:44PM  
03:15PM  
Nov-23-19 10:00AM  
Nov-20-19 09:00PM  
02:30PM  
Nov-19-19 04:03PM  
Nov-18-19 08:20PM  
03:46PM  
Nov-15-19 04:00PM  
01:41PM  
Nov-14-19 07:33PM  
03:30PM  
01:06PM  
Nov-13-19 07:52PM  
05:41PM  
03:15PM  
02:12PM  
11:30AM  
Nov-07-19 08:21AM  
Nov-05-19 06:55PM  
04:03PM  
Oct-29-19 10:32AM  
Oct-28-19 09:38AM  
Oct-22-19 04:03PM  
Oct-18-19 10:23AM  
Oct-11-19 08:19AM  
Oct-07-19 02:49PM  
Sep-10-19 04:01PM  
Sep-05-19 06:37PM  
Sep-04-19 04:22PM  
04:01PM  
Aug-27-19 04:05PM  
Aug-06-19 09:06AM  
Jul-31-19 07:55PM  
04:05PM  
Jul-24-19 04:03PM  
10:32AM  
Jul-17-19 04:03PM  
Jun-13-19 07:18AM  
Jun-05-19 04:05PM  
May-08-19 08:30AM  
05:24AM  
May-07-19 06:45PM  
04:03PM  
02:30PM  
May-02-19 12:15PM  
May-01-19 08:07PM  
Apr-30-19 10:32AM  
Apr-24-19 10:33AM  
Apr-23-19 04:05PM  
Apr-11-19 12:34PM  
Apr-10-19 04:35PM  
Apr-09-19 07:19PM  
Apr-08-19 02:03PM  
Apr-05-19 02:41PM  
10:13AM  
Apr-04-19 07:02PM  
Apr-03-19 03:45PM  
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was founded in 2006 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vort David AEVP, SalesAug 03Option Exercise8.185,26443,06021,267Aug 05 05:14 PM
Vort David AEVP, SalesAug 03Sale125.425,264660,22016,003Aug 05 05:14 PM
Vort David AEVP, SalesJul 27Option Exercise7.495,26439,41921,267Jul 29 06:36 PM
Vort David AEVP, SalesJul 27Sale121.055,264637,20716,003Jul 29 06:36 PM
Vort David AEVP, SalesJul 20Option Exercise7.475,26439,32221,267Jul 22 07:28 PM
Vort David AEVP, SalesJul 20Sale119.765,264630,41616,003Jul 22 07:28 PM
Vort David AEVP, SalesJul 13Option Exercise7.475,26439,32221,267Jul 15 07:35 PM
Vort David AEVP, SalesJul 13Sale113.915,264599,61316,003Jul 15 07:35 PM
Vort David AEVP, SalesJul 06Option Exercise7.4711,26484,14227,267Jul 08 08:13 PM
Vort David AEVP, SalesJul 06Sale114.3411,2641,287,87316,003Jul 08 08:13 PM
Vort David AEVP, SalesJun 29Option Exercise5.3311,26460,01927,267Jul 01 07:02 PM
Vort David AEVP, SalesJun 29Sale108.7111,2641,224,48916,003Jul 01 07:02 PM
Vort David AEVP, SalesJun 22Option Exercise6.2211,26470,06327,267Jun 23 08:43 PM
Vort David AEVP, SalesJun 22Sale126.4711,2641,424,55316,003Jun 23 08:43 PM
Vort David AEVP, SalesJun 15Option Exercise3.9611,26444,57127,267Jun 17 08:14 PM
Vort David AEVP, SalesJun 15Sale110.6611,2641,246,51016,003Jun 17 08:14 PM
Vort David AEVP, SalesJun 08Option Exercise3.6511,26441,11427,267Jun 10 07:13 PM
Vort David AEVP, SalesJun 08Sale119.5711,2641,346,88016,003Jun 10 07:13 PM
Scott Raymond W.DirectorJun 04Sale129.002,028261,6121,764Jun 08 05:23 PM
Vort David AEVP, SalesJun 01Option Exercise3.6511,26441,11426,943Jun 03 03:31 PM
Bairey Merz Cathleen NoelDirectorJun 01Sale125.152,804350,9221,040Jun 03 03:36 PM
Vort David AEVP, SalesJun 01Sale125.1811,2641,409,98715,679Jun 03 03:31 PM
Vort David AEVP, SalesMay 26Option Exercise3.6511,26441,11426,943May 28 03:59 PM
Vort David AEVP, SalesMay 26Sale125.1811,2641,410,06215,679May 28 03:59 PM
King Kevin MPresident and CEOMay 19Option Exercise7.6072,000547,155301,512May 21 06:57 PM
King Kevin MPresident and CEOMay 19Sale125.6272,0009,044,293229,512May 21 06:57 PM
Vort David AEVP, SalesMay 18Option Exercise3.6511,26441,11426,943May 20 07:42 PM
Bodaken Bruce G.DirectorMay 18Option Exercise41.041,70369,8916,609May 20 05:23 PM
Bodaken Bruce G.DirectorMay 18Sale131.523,003394,9593,606May 20 05:23 PM
Vort David AEVP, SalesMay 18Sale134.1611,2641,511,21915,679May 20 07:42 PM
SNYDERMAN RALPHDirectorMay 12Sale134.5525033,6384,256May 13 06:56 PM
Vort David AEVP, SalesMay 11Option Exercise3.6511,26441,11426,943May 13 06:37 PM
Vort David AEVP, SalesMay 11Sale124.1611,2641,398,50015,679May 13 06:37 PM
Vort David AEVP, SalesMay 05Option Exercise3.651,0533,84316,732May 06 04:10 PM
Vort David AEVP, SalesMay 05Sale110.001,053115,83015,679May 06 04:10 PM
Vort David AEVP, SalesMay 04Option Exercise3.659,91436,18625,890May 06 04:10 PM
Vort David AEVP, SalesMay 04Sale103.1410,2111,053,12115,679May 06 04:10 PM
King Kevin MPresident and CEOMar 24Option Exercise5.7453,004304,339282,516Mar 26 05:15 PM
King Kevin MPresident and CEOMar 24Sale80.0053,0044,240,320229,512Mar 26 05:15 PM
King Kevin MPresident and CEOMar 13Option Exercise4.004,21816,872233,730Mar 16 08:19 PM
King Kevin MPresident and CEOMar 13Sale80.004,218337,440229,512Mar 16 08:19 PM
King Kevin MPresident and CEOMar 12Option Exercise4.0014,77859,112244,290Mar 16 08:19 PM
King Kevin MPresident and CEOMar 12Sale80.2514,7781,185,914229,512Mar 16 08:19 PM
Vort David AEVP, SalesMar 06Sale97.297,440723,83816,656Mar 10 08:05 PM
SNYDERMAN RALPHDirectorMar 04Sale98.8565064,2534,506Mar 05 07:33 PM
Garrett Matthew C.Chief Financial OfficerJan 15Option Exercise14.6428,697420,07649,564Jan 17 05:25 PM
King Kevin MPresident and CEOJan 15Option Exercise4.0032,209128,836249,350Jan 17 05:22 PM
Garrett Matthew C.Chief Financial OfficerJan 15Sale80.0028,6972,295,76020,867Jan 17 05:25 PM
King Kevin MPresident and CEOJan 15Sale80.0032,2092,576,720217,141Jan 17 05:22 PM
King Kevin MPresident and CEOJan 14Option Exercise3.7539,791149,236256,451Jan 16 04:40 PM
Garrett Matthew C.Chief Financial OfficerJan 14Option Exercise8.034,95439,76925,821Jan 16 04:43 PM
Garrett Matthew C.Chief Financial OfficerJan 14Sale80.004,954396,32020,867Jan 16 04:43 PM
King Kevin MPresident and CEOJan 14Sale80.0039,7913,183,280216,660Jan 16 04:40 PM
Day Mark J.EVP, Research & DevelopmentDec 31Option Exercise7.723,29925,48039,861Jan 03 03:21 PM
King Kevin MPresident and CEODec 18Option Exercise4.7052,276245,489216,660Dec 20 01:22 PM
Garrett Matthew C.Chief Financial OfficerAug 12Option Exercise5.9827,569164,74848,436Aug 14 01:45 PM
Garrett Matthew C.Chief Financial OfficerAug 12Sale76.8327,5692,118,05220,867Aug 14 01:45 PM